advancedamlanalysisbasedburdencancercarecellcenteredchemocllcmlcommunitydecisiondevelopmentdiagnoseddiscussioneconomicfirstfuturehcthighibrutinibinhibitorleadslinelymphomamaintenancemodelingnewlyolderoncologyoutcomesovarianparppathwaypatientpatientspatternspluspracticepracticesprimarealrefractoryrelapsedresultsrisksupportsurvivaltherapytoolstreatedtreatmenttrialvalueworld